Advanced Search


Study ID Status Title Patient Level Data
207196 Recruiting A randomised, parallel-group, evaluator-blind, no-treatment and positive controlled, single-site, proof of concept clinical study to evaluate the cosmetic benefit provided by 8 weeks of twice-daily topical application of a developmental moisturising cream with niacinamide in healthy subjects with sensitive, oily, blemish-prone skin
207211 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
207212 Completed A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief from Dentinal Hypersensitivity
207213 Completed A randomized, evaluator-blind, single-center and two arm clinical study designed to evaluate the local tolerance and cosmetic efficacy of a topical skin care formulation in healthy female subjects with mild to advanced photo-damaged facial skin who have undergone a 70% Glycolic Acid facial peel procedure
207235 Completed A Human Subject 24 Hour Patch Test to Assess the Irritation Potential of Four Skin Serum Products
207236 Recruiting A Phase III, 52-week, Open-label Study to Evaluate Long-term Safety of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Patients with Asthma
207238 Completed A proof-of-principle clinical study investigating the efficacy of a dissolvable strip in providing rapid relief from dentinal hypersensitivity.
207255 Not yet recruiting Indirect treatment comparison of IV formulation and SC formulation of belimumab for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy
207264 Not yet recruiting Retrospective study of asthma patients prescribed with ICS/LABA maintenance medications using a Japan Medical Data Center (JMDC) Claim database in Japan
207266082 Completed A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of the Safety and Efficacy of SB 207266 in Patients with Symptomatic Persistent Atrial Fibrillation (AF)
207267 Not yet recruiting Assessment of Patients Treated with Albiglutide – Phase 2
207323 Active, not recruiting Burden of illness among patients with eosinophilic severe COPD
207348 Active, not recruiting Meta-analysis of studies MEA112997 and MEA115588 of mepolizumab (SB240563) in severe asthma – additional subgroup analyses of exacerbations and investigation of relationship of FEV1 to exacerbations (eTrack Study Identifier 207348)
207351 Active, Not Recruiting Observational Study to Assess Maternal and Fetal Outcomes Following Exposure to Albiglutide during Pregnancy
207387 Completed PGx7665: Exploratory Pharmacogenetic analysis of response to GSK2269557, a PI3 kinase delta inhibitor in patients from study 116678 with COPD
207389 Recruiting PGx7667 (207389) Exploratory Pharmacogenetic Investigation of Efficacy Response to mepolizumab in Eosinophilic Granulomatosis Polyangiitis (Churg-Strauss Syndrome) study 115921
207390 Not yet recruiting PGx7669: an exploratory pharmacogenetic efficacy investigation of steroid reduction in subjects with severe asthma treated with mepolizumab in 115575 and 115661
207440 Recruiting A Phase I, First Time in Human, Two Part, Randomized, Placebo-Controlled, Double-Blind (Sponsor Unblind), Single and Repeat Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK3352589, a REarranged during Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Normal Healthy Volunteers
207449 Active, Not Recruiting Ulcerative Colitis and Crohn’s Disease: Resource Utilization and costs after initiation of biologics
207451 Completed A Proof of Concept (POC) Clinical Study to Investigate the Effects of a Developmental Cosmetic Moisturising Cream on the Barrier Function of Human Skin on the Face and Forearm
207468 Completed A Proof of Concept (POC) Clinical Study to Evaluate the Appearance of Fine Lines and Wrinkles on a Developmental Cosmetic Moisturising Cream in Healthy Subjects Presenting Visible Signs of Ageing
207478 Not yet recruiting Meta-Analysis Plan for GSK sponsored studies MEA117113 and MEA117106 of Mepolizumab (SB240563) in COPD – Analysis to assess effect of mepolizumab on rate of exacerbations requiring an emergency department visit or hospitalization and rate of severe exacerbations (eTrack Study Identifier 207478)
207488 Not yet recruiting Effects of oral ambrisentan on echocardiographic measures of right ventricular structure and function in Chinese patients with pulmonary arterial hypertension
207521 Completed PGx7673: Confirmatory Genetics Reporting and Analysis Plan: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL113750 (eTrack Study ID 207521)
207523 Completed PGx7664: Exploratory PGx evaluation of ALT elevations observed in subjects treated with GSK2881078 (SARM) from study 204699



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.